Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 17

1.

In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.

Jin ZH, Josserand V, Foillard S, Boturyn D, Dumy P, Favrot MC, Coll JL.

Mol Cancer. 2007 Jun 12;6:41.

2.

Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.

Jin ZH, Josserand V, Razkin J, Garanger E, Boturyn D, Favrot MC, Dumy P, Coll JL.

Mol Imaging. 2006 Jul;5(3):188-97.

PMID:
16954034
3.

Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.

Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X.

Nano Lett. 2006 Apr;6(4):669-76.

PMID:
16608262
4.

Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to alpha v beta 3 receptor expressed in Kaposi's sarcoma.

Kwon S, Ke S, Houston JP, Wang W, Wu Q, Li C, Sevick-Muraca EM.

Mol Imaging. 2005 Apr-Jun;4(2):75-87.

PMID:
16105505
5.

New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors.

Garanger E, Boturyn D, Jin Z, Dumy P, Favrot MC, Coll JL.

Mol Ther. 2005 Dec;12(6):1168-75. Epub 2005 Jul 26.

6.

Integrin function and signaling as pharmacological targets in cardiovascular diseases and in cancer.

Paulhe F, Manenti S, Ysebaert L, Betous R, Sultan P, Racaud-Sultan C.

Curr Pharm Des. 2005;11(16):2119-34. Review.

PMID:
15974963
7.

Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression.

Achilefu S, Bloch S, Markiewicz MA, Zhong T, Ye Y, Dorshow RB, Chance B, Liang K.

Proc Natl Acad Sci U S A. 2005 May 31;102(22):7976-81. Epub 2005 May 23.

8.

Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts.

Wang W, Ke S, Wu Q, Charnsangavej C, Gurfinkel M, Gelovani JG, Abbruzzese JL, Sevick-Muraca EM, Li C.

Mol Imaging. 2004 Oct;3(4):343-51.

PMID:
15802051
9.

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.

Chen X, Conti PS, Moats RA.

Cancer Res. 2004 Nov 1;64(21):8009-14.

10.

The role of integrins in tumor angiogenesis.

Hwang R, Varner J.

Hematol Oncol Clin North Am. 2004 Oct;18(5):991-1006, vii. Review.

PMID:
15474331
11.

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies.

Haubner R, Wester HJ.

Curr Pharm Des. 2004;10(13):1439-55. Review.

PMID:
15134568
12.

Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis.

Boturyn D, Coll JL, Garanger E, Favrot MC, Dumy P.

J Am Chem Soc. 2004 May 12;126(18):5730-9.

PMID:
15125666
13.

Integrins: roles in cancer development and as treatment targets.

Jin H, Varner J.

Br J Cancer. 2004 Feb 9;90(3):561-5. Review.

14.

Role of integrins in cell invasion and migration.

Hood JD, Cheresh DA.

Nat Rev Cancer. 2002 Feb;2(2):91-100. Review.

PMID:
12635172
15.

Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

Massoud TF, Gambhir SS.

Genes Dev. 2003 Mar 1;17(5):545-80. Review. No abstract available.

16.

Optical-based molecular imaging: contrast agents and potential medical applications.

Bremer C, Ntziachristos V, Weissleder R.

Eur Radiol. 2003 Feb;13(2):231-43. Epub 2002 Aug 13. Review.

PMID:
12598985

Supplemental Content

Support Center